-

The 4th Urologic Oncology Clinical Research Conference | Professor Jun Guo on the Innovation Momentum and Future Direction of Chinese Genitourinary Oncology Research
The 4th Urologic Oncology Clinical Research Conference brought together leading experts, investigators, and innovators to review the latest progress in genitourinary oncology research in China. Alongside academic forums and international expert discussions, the meeting also released the 2025 Annual Report on Chinese Genitourinary Oncology Clinical Research, offering a comprehensive overview of the field’s recent development.
-

CSCO Guideline Preview | Professor Xinan Sheng Interprets the Core Advantages and Key Updates of the 2026 CSCO Renal Cancer Guidelines
The Chinese Society of Clinical Oncology (CSCO) Renal Cancer Guidelines have become one of the most influential and widely adopted clinical references in the field of kidney cancer in China. Built upon evidence-based medicine while remaining highly practical for everyday clinical use, the guidelines continue to evolve alongside rapid advances in renal cancer therapeutics.
-

4th Urologic Oncology Clinical Research Conference | Professor Jiwei Huang: Innovation and the Future of Non-Clear Cell RCC and UTUC
In recent years, both renal cell carcinoma and upper tract urothelial carcinoma (UTUC) have entered an era of rapid transformation, driven by advances in precision oncology, organ-preserving strategies, and systemic combination therapies.
-

J Pathology | Prof. Guoliang Yang and Prof. Xianbin Su Reveal the Molecular Landscape and Cellular Origins of Bladder Squamous Cell Carcinoma
Squamous cell carcinoma (SCC) of the bladder is a rare but highly aggressive malignancy associated with poor clinical outcomes and limited responsiveness to conventional therapies. Recently, Professor Guoliang Yang’s team from Renji Hospital, Shanghai Jiao Tong University School of Medicine, together with Professor Xianbin Su’s group from the Institute of Systems Biomedicine at Shanghai Jiao…


